Position in ACRV
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,089
+$4,833 QoQ
Shares Held
7,354
+23.8% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#31
of 46 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACRV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BARCLAYS PLC holds $1,706,205,173 across 455 Biotechnology names. ACRV ranks #321 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
733,274 | $364,239,192 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,192 | $159,745,957 | |
| 3 | IONS |
Ionis Pharmaceuticals Inc
|
1,603,136 | $127,112,653 | |
| 4 | ARGX |
Argenx SE
|
134,427 | $124,717,337 | |
| 5 | MRNA |
Moderna, Inc.
|
1,035,126 | $72,489,872 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
714,423 | $53,210,224 | |
| 7 | TGTX |
Tg Therapeutics, Inc.
|
957,848 | $52,624,168 | |
| 8 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,753 | $42,087,281 |
All Filings in ACRV
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,089 | 7,354 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $8,256 | 5,940 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $58,808 | 24,402 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $36,136 | 19,965 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $24,900 | 20,925 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $66,376 | 32,698 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $229,307 | 38,091 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $233,142 | 33,306 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $127,791 | 22,033 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $152,466 | 21,324 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $120,461 | 24,484 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $134,796 | 14,100 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $184,848 | 14,263 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $215,514 | 16,983 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $47,715 | 4,142 | Shares | Sole | 2026-03-30 | |
| No filing history on record for this holder in this stock. | ||||||